Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Mounjaro Thailand — Tirzepatide, Doctor-Led in Bangkok from ฿12,000
医生推荐
GLP-1 / GIP Program

Mounjaro Thailand — Tirzepatide, Doctor-Led in Bangkok from ฿12,000

Healthi Life · Ekkamai 10, Bangkok

Diet and exercise stop working long before the weight does. Tirzepatide acts on two incretin receptors, GIP and GLP-1, and changes what the body does with food: in the SURMOUNT-1 trial, mean body-weight change was −16.0% at 5 mg and −21.4% at 10 mg over 72 weeks, against −2.4% on placebo. At Healthi Life Ekkamai the program starts at ฿12,000 and is prescribed only after a medical intake, contraindication review and baseline labs.

起价฿12,000

2.5 mg vial, includes consultation — indicative, confirmed at physician consultation

Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

您将获得

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Injection training and monthly clinical follow-up
为什么选择此疗程

How Tirzepatide Works — Mounjaro Thailand Programmes

Dual GIP/GLP-1 Action

Tirzepatide activates two incretin receptors to support glycemic control and appetite regulation.

Physician-Supervised

Every program is initiated and titrated by a licensed physician at Healthi Life Ekkamai.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

Personal and family history screening before initiation, including MTC and MEN-2 exclusion.

Subcutaneous Injection

Weekly subcutaneous administration with in-clinic injection training and adherence support.

Longevity Integration

Coordinated with metabolic, hormone and biomarker programs for long-term outcomes.

这适合您吗?

适合人群

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Type 2 diabetes inadequately controlled on first-line therapy
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review

不建议人群

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
您的旅程

Our 4-Step Mounjaro Program

1

Medical Intake

Full history, medication review, and contraindication screening with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before the first dose.

3

Titration

Progressive dose escalation 2.5 → 5 → 7.5 → 10 mg based on tolerability and response.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

医学卓越

为什么信赖 Healthi Life

医生主导的方案、国际认证以及对曼谷客人安全的承诺。

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards

Mounjaro vs Ozempic vs Wegovy

A factual comparison of mechanism and administration. Individual response varies; all three require physician supervision.

FeatureMounjaroOzempicWegovy
MoleculeTirzepatideSemaglutideSemaglutide
Receptor targetsGIP + GLP-1 (dual)GLP-1 onlyGLP-1 only
Injection frequencyOnce weeklyOnce weeklyOnce weekly
Approved indicationType 2 diabetes + chronic weight managementType 2 diabetesChronic weight management
ManufacturerEli LillyNovo NordiskNovo Nordisk

Regulatory status

Tirzepatide is a prescription-only medicine. Under the Thai Drug Act (พ.ร.บ.ยา) a prescription medicine may not be advertised to the general public, and it may only be dispensed after a physician has assessed the individual — it cannot be bought over the counter, online, or from a non-medical seller. Registration status of a medicinal product in Thailand can be checked with the Thai Food and Drug Administration (อย.). It is not appropriate during pregnancy, when planning pregnancy or breastfeeding, with a personal or family history of medullary thyroid carcinoma or MEN-2, or with a history of pancreatitis. This page describes a supervised medical protocol; it is information, not an offer of treatment, and every decision is made with a physician.

套餐

选择您的方案

Mounjaro 2.5 mg

฿12,000

  • Starter / titration dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
选择套餐
推荐

Mounjaro 5 mg

฿15,000

  • Maintenance entry dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
选择套餐

Mounjaro 7.5 mg

฿18,000

  • Up-titration dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
选择套餐

Mounjaro 10 mg

฿20,500

  • Higher maintenance dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
选择套餐
常见问题

常见问题解答

At Healthi Life Ekkamai, Mounjaro (Tirzepatide) is prescribed for physician-supervised weight management and type 2 diabetes care. It is initiated only after medical intake, contraindication review and baseline biomarker assessment.

Pricing at Healthi Life is per vial: 2.5 mg ฿12,000, 5 mg ฿15,000, 7.5 mg ฿18,000, 10 mg ฿20,500. Each price includes one vial, physician consultation, injection training and biomarker review.

In SURMOUNT-1, a 72-week randomised placebo-controlled trial of 2,539 adults, mean body-weight change was −16.0% at 5 mg and −21.4% at 10 mg, against −2.4% on placebo. Those are the two doses used in the Healthi Life program. Individual response varies and is reviewed by the physician at every monthly follow-up.

The dose is escalated every four weeks — 2.5 → 5 → 7.5 → 10 mg — so the first month is a titration month, set by tolerability rather than by result. SURMOUNT-1 measured its full result at 72 weeks. At Healthi Life, progress and biomarkers are reviewed monthly and the dose is adjusted to what you tolerate.

Yes. Mounjaro is the Eli Lilly brand name for Tirzepatide, a dual GIP and GLP-1 receptor agonist. The FDA approved Tirzepatide for type 2 diabetes in 2022 and for chronic weight management in 2023.

This is a prescription medicine and must be initiated by a licensed physician. At Healthi Life Bangkok, prescription is preceded by an in-person consultation covering medical history, medication review, contraindication screening and baseline laboratory testing. There is no over-the-counter, online or walk-in supply.

Most guests follow a 3 to 12 month physician-supervised program, with monthly follow-up. Duration is individualized based on clinical goals, tolerability, biomarker trends and the broader longevity plan.

The most reported effects in clinical trials (SURPASS, SURMOUNT) are nausea, diarrhea, decreased appetite, vomiting and constipation, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease; report symptoms early.

Yes, under physician supervision. Mounjaro is frequently integrated with biomarker tracking, hormone optimization, peptide therapy and lifestyle medicine at Healthi Life. Combinations are reviewed for interactions at every monthly follow-up.

The FDA has approved Tirzepatide for chronic weight management in adults with obesity or overweight plus a comorbidity. At Healthi Life, eligibility, contraindications and risk-benefit are reviewed individually before any non-diabetic prescription.

Mounjaro is a prescription medicine in Thailand. At Healthi Life Ekkamai, access begins with a physician consultation covering medical history, contraindication screening and baseline laboratory testing. Once eligibility is confirmed, the physician issues a prescription and provides injection training with monthly follow-up.

Mounjaro (Tirzepatide) activates both GIP and GLP-1 receptors. Ozempic (Semaglutide) activates GLP-1 receptors only. Both are once-weekly injections manufactured by different companies (Eli Lilly vs Novo Nordisk). Mounjaro is approved for type 2 diabetes and chronic weight management; Ozempic is approved for type 2 diabetes. A physician determines which molecule aligns with the individual's metabolic profile and clinical goals.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

本页仅供一般信息参考,不构成医疗建议、诊断或治疗。个体结果存在差异。 ⁨Mounjaro — tirzepatide⁩为处方药,须经执业医师评估后方可开具与使用。本页面提供医学信息,并非广告或诊疗要约。 请务必就您的健康状况咨询合格医生。请参阅我们的 完整医疗免责声明.

Book a Mounjaro Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and a personalized titration plan.

位置

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

营业时间

Mon-Sat: 11:00 AM – 7:00 PM

响应时间:2小时内